Larimar Therapeutics Inc (LRMR)

Apr 05, 2026

Larimar surges on FDA breakthrough status for lead asset - MSN

Apr 05, 2026

Apr 04, 2026

LRMR PE Ratio & Valuation, Is LRMR Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Biotech Larimar heads to Miami for back-to-back investor meetings in March - Stock Titan

Apr 04, 2026

Apr 02, 2026

Q1 Earnings Estimate for LRMR Issued By Lifesci Capital - MarketBeat

Apr 02, 2026

Apr 02, 2026

LRMR SEC FilingsLarimar Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 02, 2026

LRMR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 02, 2026

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Apr 02, 2026

Apr 01, 2026

Larimar reports results, advances Nomlabofusp toward FDA filing - MSN

Apr 01, 2026

Apr 01, 2026

Earnings Recap: Does Larimar Therapeutics Inc have consistent dividend growthMarket Growth Review & High Conviction Buy Zone Alerts - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Buyback Watch: Is Larimar Therapeutics Incs growth already priced in2026 Weekly Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Trend Report: Is Larimar Therapeutics Inc impacted by rising ratesProfit Target & Weekly Top Gainers Trade List - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Wedbush raises its price target on Larimar Therapeutics (LRMR) to $13 - MSN

Mar 31, 2026

Mar 28, 2026

Profit Recap: Will Larimar Therapeutics Inc stock hit new highs in YEAR2026 Earnings & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13 - Insider Monkey

Mar 27, 2026

Mar 26, 2026

Larimar Reports Results, Advances Nomlabofusp Toward FDA Filing - MyChesCo

Mar 26, 2026

Mar 26, 2026

Larimar Therapeutics (NASDAQ:LRMR) Stock Rating Upgraded by Truist Financial - MarketBeat

Mar 26, 2026

Mar 26, 2026

RSI Check: Will Larimar Therapeutics Inc benefit from geopolitical trendsWeekly Trading Summary & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Larimar heads to JPMorgan as rare disease program draws investor attention - MSN

Mar 25, 2026

Mar 23, 2026

Larimar Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 23, 2026

Mar 23, 2026

Larimar Therapeutics (LRMR) Expected to Announce Earnings on Monday - MarketBeat

Mar 23, 2026

Mar 21, 2026

Institution Moves: Is Larimar Therapeutics Inc impacted by rising ratesTrade Exit Report & Low Risk Entry Point Tips - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.2% After Analyst Upgrade - MarketBeat

Mar 20, 2026

Mar 20, 2026

Wedbush Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $13.00 - MarketBeat

Mar 20, 2026

Mar 20, 2026

LRMR Stock: Wedbush Raises Price Target to $13, Maintains Outper - GuruFocus

Mar 20, 2026

Mar 20, 2026

Larimar Therapeutics (LRMR) Q4 EPS Misses Estimates - gurufocus.com

Mar 20, 2026

Mar 19, 2026

Larimar Therapeutics stock rating reiterated by William Blair - Investing.com Canada

Mar 19, 2026

Mar 19, 2026

Nomlabofusp push at Larimar Therapeutics (NASDAQ: LRMR) targets 2026 BLA - Stock Titan

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics reports Q4 EPS (73c), consensus (55c) - TipRanks

Mar 19, 2026

Mar 19, 2026

FDA grants breakthrough status to Larimar’s nomlabofusp - MSN

Mar 19, 2026

Mar 19, 2026

Larimar (LRMR) Poised for Milestone Achievements and Financial S - gurufocus.com

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics, Inc. has established a clear regulatory approval and commercialization timeline for its core candidate product. - Bitget

Mar 19, 2026

Mar 19, 2026

Larimar: Q4 Earnings Snapshot - KTVB

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics Receives Breakthrough Therapy Designation for Nomlabofusp in Friedreich's Ataxia, Plans BLA Submission for June 2026 - Quiver Quantitative

Mar 19, 2026

Mar 19, 2026

LRMR: Nomlabofusp advances toward BLA submission with strong cash position and FDA alignment - TradingView

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Mar 19, 2026

Mar 19, 2026

Larimar Therapeutics Q4 net loss widens on higher R&D costs - TradingView

Mar 19, 2026

Mar 19, 2026

Larimar (NASDAQ: LRMR) secures FDA Breakthrough status and funds runway to 2027 - Stock Titan

Mar 19, 2026

Mar 19, 2026

BRIEF-Larimar Therapeutics Q4 Net Income USD -62.498 Million - TradingView

Mar 19, 2026

Mar 19, 2026

FDA grants Breakthrough status to rare disease drug as June filing nears - Stock Titan

Mar 19, 2026

Mar 17, 2026

IPO Launch: Does Larimar Therapeutics Inc have consistent dividend growth2026 Summary & Risk Managed Trade Strategies - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Should I invest in Larimar Therapeutics Inc before earningsSwing Trade & Growth Focused Investment Plans - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Larimar Therapeutics Reports Q1 2025 Results and Advances Nomlabofusp Development - MSN

Mar 16, 2026

Mar 16, 2026

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Sees Significant Decrease in Short Interest - MarketBeat

Mar 16, 2026

Mar 14, 2026

Aug Gainers: How volatile is Larimar Therapeutics Inc stockTrade Exit Summary & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 14, 2026

Mar 14, 2026

Mangrove Partners IM LLC Sells 327,997 Shares of Larimar Therapeutics, Inc. $LRMR - MarketBeat

Mar 14, 2026